LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr | ₹1,136 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,390 Cr |
| Mar2024 | ₹820 Cr |
| Mar2023 | ₹992 Cr |
| Mar2022 | ₹1,153 Cr |
| Mar2021 | ₹1,136 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,390 Cr | 191.57 | |
| Mar2024 | ₹820 Cr | -17.38 | |
| Mar2023 | ₹992 Cr | -13.96 | |
| Mar2022 | ₹1,153 Cr | 1.50 | |
| Mar2021 | ₹1,136 Cr | - | |
Compare Total Non-Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹103,962.7 Cr | 1.3% | -2.8% | 10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 1.3% |
-2.8% |
10.6% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses